Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCRC”

342 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 342 results

Testing effectiveness (Phase 2)WithdrawnNCT05412706
What this trial is testing

Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy

Who this might be right for
Metastatic Colorectal Cancer
Ospedale Policlinico San Martino
Large-scale testing (Phase 3)Ended earlyNCT05328908
What this trial is testing

Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Bristol-Myers Squibb 770
Large-scale testing (Phase 3)Study completedNCT03511963
What this trial is testing

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai Henlius Biotech 677
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938
What this trial is testing

Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more
Tao Zhang 70
Large-scale testing (Phase 3)Study completedNCT01571284
What this trial is testing

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Who this might be right for
Colorectal Cancer Metastatic
Sanofi 781
Testing effectiveness (Phase 2)Study completedNCT01345526
What this trial is testing

Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream

Who this might be right for
Metastatic Colorectal Cancer
Universitätsmedizin Mannheim 124
Testing effectiveness (Phase 2)Study completedNCT01703390
What this trial is testing

Biomarker Directed Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Arbeitsgemeinschaft medikamentoese Tumortherapie 47
Testing effectiveness (Phase 2)UnknownNCT00931840
What this trial is testing

EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Enzon Pharmaceuticals, Inc. 220
Early research (Phase 1)Ended earlyNCT04044430
What this trial is testing

Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal Carcinoma+25 more
University of California, San Francisco 2
Testing effectiveness (Phase 2)UnknownNCT04753203
What this trial is testing

Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients

Who this might be right for
Metastatic Colorectal CancerPIK3CA Gene Mutation
Korean Cancer Study Group 65
Large-scale testing (Phase 3)Study completedNCT01931150
What this trial is testing

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Who this might be right for
Cetuximab-induced Papulopustular (Acneiform) Rash Who HaveMetastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05312398
What this trial is testing

CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen

Who this might be right for
Metastatic Colorectal Adenocarcinoma
University of Campania Luigi Vanvitelli 219
Testing effectiveness (Phase 2)Study completedNCT02368886
What this trial is testing

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Colon AdenocarcinomaRectal AdenocarcinomaStage III Colorectal Cancer AJCC v7+6 more
Academic and Community Cancer Research United 123
Large-scale testing (Phase 3)Active Not RecruitingNCT03828227
What this trial is testing

QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric Parameters.

Who this might be right for
Elderly PatientsMetastatic Colorectal CancerQuality of Life
GERCOR - Multidisciplinary Oncology Cooperative Group 49
Testing effectiveness (Phase 2)Study completedNCT03442569
What this trial is testing

PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC

Who this might be right for
Colon Cancer
UNC Lineberger Comprehensive Cancer Center 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04034173
What this trial is testing

Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation

Who this might be right for
Treatment Related Cancer
Ludwig-Maximilians - University of Munich 120
Large-scale testing (Phase 3)Study completedNCT02394795
What this trial is testing

Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC

Who this might be right for
Colorectal Cancer
Takeda 823
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Looking for participantsNCT06148402
What this trial is testing

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer

Who this might be right for
Unresectable/Metastatic Colorectal Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)UnknownNCT06039202
What this trial is testing

Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Holy Stone Healthcare Co., Ltd 100
Load More Results